Life SciencesPharmaceuticalsTherapeutic AreaCNS/Neurology

Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size, Status and Forecast 2018-2025

Lowest Prices Guaranteed Length Publisher Published Date SKU
from $3,900 97 Pages QYResearch Group October, 2018 QYR15798076
Lowest Prices Guaranteed
Price from $3,900
Length 97 Pages
Publisher QYResearch Group
Published Date October, 2018
SKU QYR15798076

Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size, Status and Forecast 2018-2025

This report studies the Amyotrophic Lateral Sclerosis (ALS) Treatment market status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top company in global and major regions, and splits the Amyotrophic Lateral Sclerosis (ALS) Treatment market by product type and applications/end industries.

In the last several years, global market of Amyotrophic Lateral Sclerosis (ALS) Treatment developed smoothly, with an average growth rate of 21% during 2013 to 2018. The principal reason was contribution made by Radicava, which was launched in the USA in August 2017. And Radicava has gotten off to a strong start. In 2017, global revenue of Amyotrophic Lateral Sclerosis (ALS) Treatment is nearly 197 million USD.

The major players in global Amyotrophic Lateral Sclerosis (ALS) Treatment market include
Mitsubishi Tanabe Pharma
Sanofi
Mylan Pharma
Apotex
Glemark Generics
Covis Pharma
Sun Pharma
Lunan Pharma

Geographically, this report is segmented into several key regions, with production, sales, revenue, market share and growth rate of Amyotrophic Lateral Sclerosis (ALS) Treatment in these regions, from 2013 to 2025 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
South America
Rest of World

On the basis of product, the Amyotrophic Lateral Sclerosis (ALS) Treatment market is primarily split into
Riluzole
Edaravone (Radicava)
Other

On the basis on the end users/applications, this report covers
Hospital
Drugs Store
Other


1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate by Type (2013-2025)
1.4.2 Riluzole
1.4.3 Edaravone (Radicava)
1.5 Market by Application
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size
2.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Growth Trends by Regions
2.2.1 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Regions (2013-2025)
2.2.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Manufacturers
3.1.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue by Manufacturers (2017-2018)
3.1.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Manufacturers (2017-2018)
3.1.3 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Concentration Ratio (CR5)
3.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Key Players Head office and Area Served
3.3 Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Product/Solution/Service
3.4 Date of Enter into Amyotrophic Lateral Sclerosis (ALS) Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2013-2018)
4.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2013-2018)
5 North America
5.1 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market (2013-2018)
5.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Key Players in North America
5.3 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type
5.4 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application
6 Europe
6.1 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market (2013-2018)
6.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Key Players in Europe
6.3 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type
6.4 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application
7 China
7.1 China Amyotrophic Lateral Sclerosis (ALS) Treatment Market (2013-2018)
7.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Key Players in China
7.3 China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type
7.4 China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application
8 Japan
8.1 Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market (2013-2018)
8.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Key Players in Japan
8.3 Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type
8.4 Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market (2013-2018)
9.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Key Players in Southeast Asia
9.3 Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type
9.4 Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application
10 India
10.1 India Amyotrophic Lateral Sclerosis (ALS) Treatment Market (2013-2018)
10.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Key Players in India
10.3 India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type
10.4 India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application
11 South America
11.1 South America Amyotrophic Lateral Sclerosis (ALS) Treatment Market (2013-2018)
11.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Key Players in South America
11.3 South America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type
11.4 South America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application
12 Analysis of Amyotrophic Lateral Sclerosis (ALS) Treatment Industry Key Manufacturers
12.1 Mitsubishi Tanabe Pharma
12.1.1 Company Profile
12.1.2 Product Information
12.1.3 Revenue and Gross Margin
12.2 Sanofi
12.2.1 Company Profile
12.2.2 Product Information
12.2.3 Revenue and Gross Margin
12.3 Mylan Pharma
12.3.1 Company Profile
12.3.2 Product Information
12.3.3 Revenue and Gross Margin
12.4 Apotex
12.4.1 Company Profile
12.4.2 Product Information
12.4.3 Revenue and Gross Margin
12.5 Glemark Generics
12.5.1 Company Profile
12.5.2 Product Information
12.5.3 Revenue and Gross Margin
12.6 Covis Pharma
12.6.1 Company Profile
12.6.2 Product Information
12.6.3 Revenue and Gross Margin
12.7 Sun Pharma
12.7.1 Company Profile
12.7.2 Product Information
12.7.3 Revenue and Gross Margin
12.8 Lunan Pharma
12.8.1 Company Profile
12.8.2 Product Information
12.8.3 Revenue and Gross Margin
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 North America
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Table and Figure
Table Amyotrophic Lateral Sclerosis (ALS) Treatment Key Market Segments
Table Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Covered
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate by Type (2013-2025) (M USD)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Type in 2018
Figure Riluzole Features
Table of Key Players of Riluzole
Figure Edaravone (Radicava) Features
Table of Key Players of Edaravone (Radicava)
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth by Application (2013-2025) (M USD)
Figure Amyotrophic Lateral Sclerosis (ALS) Treatment Report Years Considered
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size and Growth Rate 2013-2025 (M USD)
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Regions 2013-2025 (M USD)
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Regions 2013-2018 (M USD)
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Regions 2013-2018
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Regions 2013-2018
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Regions 2018
Table Market Drivers
Figure Global GDP Growth Rate for 2016
Figure Real GDP Growth 2016-2020 Annual Average
Figure USA GDP 2008-2016 (Billion USD)
Figure USA GDP Growth Rate Change 2015-2018
Figure EU GDP 2008-2016 (Billion USD)
Figure EU GDP Growth Rate Change 2015-2018
Figure Germany GDP 2008-2016 (Billion USD)
Figure Germany GDP Growth Rate 2015-2018
Figure UK GDP 2008-2016 (Billion USD)
Figure UK GDP Growth Rate 2015-2018
Figure Italy GDP 2008-2016 (Billion USD)
Figure Italy GDP Growth Rate 2015-2018
Figure France GDP 2008-2016 (Billion USD)
Figure France GDP Growth Rate 2015-2018
Figure Japan GDP 2008-2016 (Billion USD)
Figure Japan GDP Growth Rate 2015-2018
Figure China GDP 2008-2016 (Billion USD)
Figure China GDP Growth Rate 2015-2018
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue by Manufacturers (2017-2018) (M USD)
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Manufacturers (2017-2018)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Manufacturers in 2017
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Manufacturers in 2018
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Manufacturers Market Concentration Ratio (CR5)
Table Key Players Head office and Area Served
Table Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Product/Solution/Service
Table Date of Enter into Amyotrophic Lateral Sclerosis (ALS) Treatment Market
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2013-2018) (M USD)
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Share by Type (2013-2018)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Type (2013-2018)
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2013-2018) (M USD)
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Share by Application (2013-2018)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Application (2013-2018)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Application in 2018
Figure North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2013-2018 (M USD)
Table North America Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (2017-2018) (M USD)
Table North America Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share (2017-2018)
Table North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2013-2018) (M USD)
Table North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2013-2018)
Table North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2013-2018) (M USD)
Table North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2013-2018)
Figure Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2013-2018 (M USD)
Table Europe Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (2017-2018) (M USD)
Table Europe Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share (2017-2018)
Table Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2013-2018) (M USD)
Table Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2013-2018)
Table Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2013-2018) (M USD)
Table Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2013-2018)
Figure China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2013-2018 (M USD)
Table China Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (2017-2018) (M USD)
Table China Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share (2017-2018)
Table China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2013-2018) (M USD)
Table China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2013-2018)
Table China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2013-2018) (M USD)
Table China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2013-2018)
Figure Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2013-2018 (M USD)
Table Japan Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (2017-2018) (M USD)
Table Japan Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share (2017-2018)
Table Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2013-2018) (M USD)
Table Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2013-2018)
Table Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2013-2018) (M USD)
Table Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2013-2018)
Figure Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2013-2018 (M USD)
Table Southeast Asia Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (2017-2018) (M USD)
Table Southeast Asia Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share (2017-2018)
Table Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2013-2018) (M USD)
Table Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2013-2018)
Table Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2013-2018) (M USD)
Table Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2013-2018)
Figure India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2013-2018 (M USD)
Table India Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (2017-2018) (M USD)
Table India Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share (2017-2018)
Table India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2013-2018) (M USD)
Table India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2013-2018)
Table India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2013-2018) (M USD)
Table India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2013-2018)
Figure South America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2013-2018 (M USD)
Table South America Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (2017-2018) (M USD)
Table South America Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share (2017-2018)
Table South America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2013-2018) (M USD)
Table South America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2013-2018)
Table South America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2013-2018) (M USD)
Table South America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2013-2018)
Table Mitsubishi Tanabe Pharma Company Profile
Figure Amyotrophic Lateral Sclerosis (ALS) Treatment Product Picture of Mitsubishi Tanabe Pharma
Table Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (M USD) and Gross Margin of Mitsubishi Tanabe Pharma 2017-2018
Table Sanofi Company Profile
Figure Amyotrophic Lateral Sclerosis (ALS) Treatment Product Picture of Sanofi
Table Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (M USD) and Gross Margin of Sanofi 2017-2018
Table Mylan Pharma Company Profile
Figure Amyotrophic Lateral Sclerosis (ALS) Treatment Product Picture of Mylan Pharma
Table Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (M USD) and Gross Margin of Mylan Pharma 2017-2018
Table Apotex Company Profile
Figure Amyotrophic Lateral Sclerosis (ALS) Treatment Product Picture of Apotex
Table Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (M USD) and Gross Margin of Apotex 2017-2018 58

$3,900
$7,800
 
Research assistance
US: 800.298.5699
Int'l: +1.240.747.3093
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks